Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$21,027,793
+$3,472,001 QoQ
Shares Held
83,563
+3.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#590
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ethic Inc. holds $332,739,634 across 14 Drug Manufacturers - General names. ABBV ranks #5 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,920 | $109,052,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
358,041 | $46,008,268 | |
| 3 | JNJ |
Johnson & Johnson
|
109,758 | $27,875,239 | |
| 4 | PFE |
Pfizer Inc
|
882,175 | $21,242,774 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
83,563 | $21,027,793 | |
| 6 | AMGN |
Amgen Inc
|
56,184 | $20,345,350 | |
| 7 | NVS |
Novartis AG
|
108,784 | $17,048,628 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
270,904 | $15,609,488 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,027,793 | 83,563 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $17,555,792 | 80,720 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $16,555,471 | 72,456 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $16,049,195 | 69,315 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $12,210,083 | 65,780 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $14,204,827 | 67,797 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $17,358,624 | 97,685 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,292,336 | 87,565 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,239,342 | 94,679 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $15,945,586 | 87,565 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,977,192 | 38,570 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,216,503 | 34,996 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,353,530 | 32,313 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,769,353 | 36,201 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,939,652 | 36,753 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,042,267 | 52,472 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,448,936 | 48,635 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $5,166,283 | 31,869 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,668,192 | 19,706 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,044,244 | 18,951 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,001,031 | 8,887 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,337,382 | 12,358 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,754,474 | 16,374 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,702,224 | 19,434 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $1,478,590 | 15,060 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $822,547 | 10,796 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||